Hema-Chek Trademark Details

Hema-Chek was registered on Tuesday, December 27, 1983 and is currently owned by Siemens Healthcare Diagnostics Inc. under the registration number 1262093 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 11 years ago on Saturday, February 23, 2013, according to the United State Patent & Trademark Office
Word Mark Hema-Chek
Status Alive Registered 800 — Registered and Renewed

Current Owner

Siemens Healthcare Diagnostics Inc. of Los Angeles, CA

View all trademarks for Siemens Healthcare Diagnostics Inc.
Other Trademarks for Siemens Healthcare Diagnostics Inc.

Previous Owners

Miles Laboratories, Inc. of Elkhart, IN

View all trademarks for Miles Laboratories, Inc.
Other Trademarks for Miles Laboratories, Inc.

Miles Inc. of Elkhart, IN

View all trademarks for Miles Inc.
Other Trademarks for Miles Inc.

Bater Corporation of Pittsburgh, PA

View all trademarks for Bater Corporation
Serial Number 73357216
Registration Number 1262093
Status Date Saturday, February 23, 2013
Filing Date Saturday, February 23, 2013
Registration Date Tuesday, December 27, 1983
Attorney Cynthia G. Tymeson and Jill Anderfuren

Correspondent

Cynthia G. Tymeson
SIEMENS HEALTHCARE DIAGNOSTICS INC.
1717 DEERFIELD RD
DEERFIELD IL 60015-3900

Case File Statements

Goods & Services Chemical Reagent Test for Qualitative Determination of Fecal Occult Blood
Pseudo Mark Hema-Check

Classifications

International Class Codes
001 — Class 1 includes mainly chemical products used in industry, science and agriculture, including those which go to the making of products belonging to other trademark classes. Examples include compost, salt for preserving non-foodstuffs, and certain additives for the food industry.
U.S. Class Codes 006
Status 6 — Active
Status Date Tuesday, December 27, 1983
First Use Anywhere Friday, October 9, 1981
First Use In Commerce Friday, October 9, 1981
Primary Code 001

You must be signed in to print.

Once signed in, look for the PDF button.